Johne's Disease Diagnostics Market Size & Share 2024 – 2032

Johne’s Disease Diagnostics Market Size

The global Johne’s disease diagnostics market size was valued at USD 645.6 million in 2023 and is poised to grow at 5.2% CAGR from 2024 to 2032. This growth is attributed to the increasing awareness of the disease and the productivity concerns of the livestock sector.

Mycobacterium avium subspecies paratuberculosis (MAP) causes Johne’s disease, which is a chronic gastrointestinal infection mainly found in cattle, sheep, and goats. USDA's National Animal Health Monitoring System (NAHMS) recently reported that the infection impacts nearly 68% of U.S. dairy herds, with noted economic losses of approximately USD 200 to 250 million per year. In Europe, a 2022 Journal of Dairy Science study reported country-level prevalence rates ranging from 20% to 50%. These figures highlight the growing need for advanced diagnostic solutions in the global livestock industry.
 

In addition, diagnostic technologies like PCR and other serological tests continue to evolve. They have improved both the speed and the accuracy of the diagnosis, which makes these methods more appealing to veterinary practitioners and other livestock producers. Moreover, as there is a growing concern for animal welfare and adoption of sustainable farming practices, producers are adopting reliable diagnostic methods for identifying and managing infected animals. Therefore, such factors together are contributing to the growth of the Johne’s disease diagnostics market.
 

In Johne’s disease diagnostics, there is the identification of MAP by several procedures like the detection of antibodies by Enzyme-Linked Immunosorbent Assay (ELISA) and identification of MAP's DNA in fecal samples using Polymerase Chain Reaction (PCR). Prompt and accurate diagnosis is essential for the control of disease spread as well as minimizing negative repercussions for the livestock industries.
 

Johne’s Disease Diagnostics Market Trends

• The growth of the Johne’s disease diagnostic market is driven by eradication programs and rising knowledge of paratuberculosis.
   
  • For instance, the Irish Johne’s Control Programme (IJCP) demonstrate comprehensive approach for managing Irish cattle industry and control the disease. As of 2021, more than 1,800 herds had joined the program, which is estimated to be about 15% of the country’s dairy herds.
     
  • The program also promotes biosecurity and improves calf health, as well as efforts towards secure sustainable cattle farming for Ireland. This proactive approach necessitates regular testing and further leads to the increasing demand for accurate diagnostic tools for disease management.
     
• In the U.S., the USDA's Animal and Plant Health Inspection Service (APHIS) has set up a cooperative Federal-State-Industry Johne’s Disease Control Program. The USDA estimates that around 68% of the dairy herds in the U.S. are affected by Johne’s disease and that this results in a loss between USD 200 million and USD 250 million for the dairy industry.
   
• The growing concern of this disease leads to more funding for research to develop new measures. From 2015 to 2020, the USDA's National Institute of Food and Agriculture (NIFA) spent over USD 5 million in grants for Johne’s disease research.
   
• These initiatives highlight the growing recognition of paratuberculosis in livestock health and fueling the demand for diagnostic kits and thereby propelling market growth.
   

Johne’s Disease Diagnostics Market Analysis

Based on test type, the market is classified into Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), and Agar Gel Immunodiffusion (AGID). The PCR segment dominated the market with 45.3% of the market share in 2023.
 

• The significant growth of this segment can be attributed to their sensitivity, high accuracy, and the early detection of mycobacterium avium subspecies paratuberculosis (MAP).
   
• Also, owing to the advancements in PCR technologies which makes the diagnosis more accessible, cost-effective and easy for veterinary diagnostics results in widespread acceptance and adoption of this segment.
   
• Furthermore, with the rising awareness about the economical impact of Johne’s disease on livestock production and growing demand for reliable diagnostic tools, the PCR segment has emerged as the preferred choice, ensuring its dominant position in the market.

Learn more about the key segments shaping this market

Download Free PDF

Based on animal type, the Johne’s disease diagnostics market is segmented into cattle, goats, sheep, and other animal types. The cattle segment accounted for USD 581.7 million in 2023.
 

• Cattle, especially dairy herds, are very sensitive to Mycobacterium avium subspecies paratuberculosis which is the causative organism of Johne's disease. Its widespread prevalence has established a market need for diagnostic products in the cattle segment.
   
• The disease has a profound negative effect on cattle such as weight loss, low milk yield and poor health of the infected animals which results in significant losses in the dairy and beef farming businesses.
   
• To manage the disease and minimize the impact, early detection through diagnostic tools significantly contributes to the growth.

The North America Johne’s disease diagnostics market was valued at USD 271.8 million in 2023 and is expected to grow lucratively at a 5.1% CAGR over the analysis period.
 

• The increasing awareness among livestock producers, advanced veterinary infrastructure and stringent regulations for disease control solidifies North America’s dominant position in the global market.
   
• Also, increased safety and quality requirements for meat products continue to propel the growth of the market. For instance, the National Institutes of Health (NIH) data indicate that American people aged 2 years and older consume, on average, 42.2 grams or 1.5 ounces of beef per day. This high consumption rate results in increased focus on maintaining healthy cattle herds, as diseases like Johne's can significantly impact beef production.
   
• Thus, for managing such diseases, effective diagnostic tools are essential to get early treatment and ensure a consistent beef supply. These factors are expected to contribute to the continued growth of the market in North America.
   

The U.S. Johne’s disease diagnostics market accounted for USD 248.7 million in 2023 and is projected to reach USD 380.9 million by 2032.
 

• The market growth is supported by strong governmental initiatives targeting frequent testing, herd management programs, and risk assessments to control Johne’s disease.
   
• Moreover, the market is bolstered by the growing use of advanced diagnostic technologies like PCR and ELISA, which significantly improve the sensitivity and rapidity of disease detection.
   
• Collectively, these factors create a robust environment for the growth of the market in the U.S. to flourish in the upcoming years.
   

The China Johne’s disease diagnostics market is anticipated to experience remarkable growth over the forecast period.
 

• The prevalence of Johne’s disease in Chinese dairy herds increased from 2.5% in 2015 to 3.8% in 2020, as per the China Animal Health and Epidemiology Center. This high prevalence demonstrates the increasing demand for effective Johne’s disease diagnostics, thereby driving the growth of China market.
   
• Furthermore, the growing awareness of the early diagnosis and treatment of Johne’s disease has contributed to the market growth. For instance, as per a survey conducted by the Chinese Veterinary Medical Association in 2022 states that 72% of livestock veterinarians now find it necessary to screen for Johne's disease, as opposed to needing it in 58% of cases, as was the situation in 2018.
   
• This shift in the perception of the necessity of testing for Johne’s disease is likely to increase the use of diagnostic tools and services, benefiting the overall market.
   

India is expected to showcase significant growth in the global Johne’s disease diagnostics market.
 

• As per the 20th Livestock Census, the total bovine stock in India comprising cattle, buffalo, gayal/ Drung ox, and yak was estimated to be 302.79 million in 2019 which was an increase of 1.0% compared to the census. This reflects the increasing livestock sector that requires effective disease management solutions including the diagnosis of Johne’s disease.
   
• The growing concern over the quality of meat and milk, in conjunction with the need to maintain animal health, is creating greater demand for advanced diagnostic tools which is profoundly impacting the market’s growth.
   

Johne’s Disease Diagnostics Market Share

The market is currently competitive with the presence of key players each striving to capture a sizable share of the market, which is growing due to advances in diagnostic technologies such as PCR and ELISA which improve disease detection precision and speed.  Thermo Fisher Scientific, VMRD, and IDEXX Laboratories are pioneers in the industry as they broaden their scope of innovative diagnostic solutions to include livestock, cattle, and goats.
 

Johne’s Disease Diagnostics Market Companies

Prominent players operating in the Johne’s disease diagnostics industry include:

• BioMérieux SA
• Idexx Laboratories, Inc.
• INDICAL BIOSCIENCE GmbH
• Innovative Diagnostics (IDvet)
• MV Diagnostics
• Pictor diagnostics
• Tetracore, Inc.
• Thermo Fisher Scientific Inc.
• VMRD, Inc.
• Zoetis Inc.
   

Johne’s Disease Diagnostics Industry News:

• In July 2020, VMRD received USDA approval to test goat serum with their Johne’s antibody test kit. This new development adds to the existing USDA licensure for bovine serum and milk samples, which are already utilized in laboratories throughout the U.S. and globally. This helped the company diversify its product offerings, enabling them to cater to a broader range of livestock species.
   

The Johne’s disease diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Test Type

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Polymerase Chain Reaction (PCR)
• Agar Gel Immunodiffusion (AGID)

Market, By Animal Type

• Cattle
• Goat
• Sheep
• Other animal types

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa